Diabetic foot ulcers can take up to 150 days to heal. A biomedical engineering team wants to reduce it to 21 days.
They’re planning to drop the healing time by amplifying what the body already does naturally: build layers of new tissue pumped up by nitric oxide. In patients with diabetes, impaired nitric oxide production lessens the healing power of skin cells, and the Centers for Disease Control reports that 15 percent of Americans living with Type 2 diabetes struggle with hard-to-heal foot ulcers. However, simply pumping up nitric oxide is not necessarily better. The long-term plan of Michigan Technological University researchers is to create nitric oxide-infused bandages that adjust the chemical release depending on the cell conditions.
To do that, the researchers first have to figure what’s going on with nitric oxide in skin cells. Assessing nitric oxide under diabetic and normal conditions in human dermal fibroblast cells is the focus of the team’s latest paper, published this week in Medical Sciences (DOI: 10.3390/medsci6040099).
Cell-mediated Symphony of Complexity
Megan Frost is the interim chair of the Department of Kinesiology and Integrative Physiology as well as an associate professor of biomedical engineering and an affiliated associate professor of materials science and engineering. She runs a polymeric biomaterials lab at Michigan Tech where she works on nitric oxide-releasing technology.
“Nitric oxide is a powerful healing chemical, but it’s not meant to be heavy-handed,” Frost says. “We’re looking at the profiles of healthy and diabetic cells to find a more nuanced way to recover wound function.”
As a wound heals, three types of skin cells step in. Macrophages are the first responders—and the most widely studied cells—that arrive within 24 hours of damage. Next, fibroblasts arrive, which are like the body’s engineers. They help lay down the extracellular matrix that makes it possible for the next cells, keratinocytes, to do the heavy-lifting and rebuilding.
“Wound healing is a complex, cell-mediated symphony of events, progressing through a series of predictable and overlapping stages,” Frost and her team write in their Medical Sciences paper. When any part of that orchestra is out of tune, the whole process falls flat. Fibroblasts, which are not as well studied as macrophages in the healing process, are a key instrument, and past studies have shown their delayed response in patients with diabetes may be a major factor in slow healing time.
Nitric Oxide vs. Nitrite
That’s where nitric oxide steps in, a kind of chemical metronome to get the process back into the right rhythm. But the body’s dermal orchestra is not so simple—just as playing a metronome louder and louder isn’t necessarily going to make a musician’s timing improve, flooding a wound with nitric oxide isn’t a cure-all.
“The old approach is to add nitric oxide and sit back to see if it works,” Frost says. “What we’re finding is that it’s not enough to apply and leave; we have to keep tabs on how much nitric oxide is actually needed.”
A big problem that Frost and her team address is how nitric oxide is measured in the first place. Current practice substitutes measuring nitrite for nitric oxide—a misleading switch, Frost says, because nitrite is a byproduct with no time signature. While stable nitrite is easier to measure, by itself it cannot relay the real-time healing status like nitric oxide levels can.
So, Frost’s lab built a nitric oxide-measuring device for their study by hand. That creates a challenge since it means taking measurements is much harder, which limits the dataset size, but Frost has an agreement with Zysense LLC to streamline the building process and produce commercial nitric oxide measurement devices that would improve cell chemistry research.
Collaboration is a key part of the engineering design process. To build a nitric oxide bandage with personalized healing power, the team plans to work next with the UP Portage Health System to gather cell samples from local patients. By expanding their cell samples—and applying the tech to real-world patients—the team will continue to broaden their database while deepening their knowledge of nitric oxide mechanisms.
In a few years, they plan to have a working bandage prototype, one that leaves off the clunky nitrite proxies and nitric oxide dumps. Instead, patients dealing with diabetic foot ulcers will see a light at the end of the tunnel much sooner than half a year or more—the nitric oxide-releasing bandage could help heal one of health care’s toughest diseases in less than a month.
The Latest on: Diabetic ulcers
via Google News
The Latest on: Diabetic ulcers
- Global Diabetic Foot Ulcer Treatment Market Size, Competitive Analysis, Share, Forecast- 2019-2025on December 2, 2020 at 8:36 am
The global diabetic foot ulcer treatment market is anticipated to grow at a CAGR of around 7% during the forecast ...
- Diabetic Foot Ulcers Therapeutics Market | Forecasting Strategy to Undergo a Paradigm Shift From Crisis to New Normal During COVID-19 Pandemic | Technon November 27, 2020 at 4:03 pm
DiabeticFootUlcersTherapeuticsMarket--The diabetic foot ulcers therapeutics market is poised to grow by USD 986.41 million during 2020-2024, progressing at a CAGR of almost 9% during the forecast ...
- When Should One Screen For Osteomyelitis In Non-Healing Ulcers?on November 24, 2020 at 11:22 am
Patients who have diabetes complicated by any degree of peripheral neuropathy are inherently at an increased risk for developing ulcers and infections. When patients with diabetes present with an ...
- Did you know diabetes can give you frequent urinary tract infections?on November 23, 2020 at 11:16 pm
Diabetes causes insulin resistance. Without enough insulin, glucose remains in the blood. Presence of excess glucose in the bloodstream can increase the risk of several diseases including ...
- Diabetic Foot Ulcer Therapeutics Market Size to accrue $ 5372.6 million by 2025on November 22, 2020 at 8:32 pm
The global Diabetic Foot Ulcer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.5% in the forecast period of 2020 to 2025 and will ...
- PDRH observes November as Diabetes Awarness Monthon November 20, 2020 at 9:00 pm
November is Diabetes Awareness Month and it is thought that around 30 million residents in the United States have diabetes, and another 80 million are living with pre-diabetes.
- DR MICHAEL MOSLEY: Why won't the NHS tell you how to treat diabetes?on November 20, 2020 at 2:22 pm
I was delighted last week by the news from the Norfolk Diabetes Prevention Study which showed that even modest weight loss can have a big impact.
- Study: Use of Daily Foot-Temperature Sensing Mat Avoids Amputation In Patients With Diabeteson November 19, 2020 at 2:01 pm
Use of innovative technology also reduced hospital admissions, as well as ER and outpatient visits. A study of patients at high risk of developing diabetic foot complications saw major amputations ...
- The Messina Lab is Developing a Treatment for Previously Non-Healing Wounds in People with Type 2 Diabeteson November 18, 2020 at 6:29 am
UMass Diabetes Center of Excellence research in The Messina Lab at University of Massachusetts Medical School is developing a treatment for diabetes wound healing.
via Bing News